---
$id: https://graph.org.ai/products/commodity/51392806
$type: Product
source: UNSPSC
code: "51392806"
title: "Imazodan hydrochloride"
class: "51392800"
classTitle: "Sympathomimetic or adrenergic pyridazines"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Imazodan hydrochloride

**UNSPSC Code**: 51392806
**Class**: [Sympathomimetic or adrenergic pyridazines](Sympathomimetic or adrenergic pyridazines.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor with the molecular formula C13H12N4O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5EP74J9Q34, chemically known as 4,5-dihydro-6-(p-imidazol-1-ylphenyl)-3(2h)-pyridazinone monohydrochloride but more generally known as imazodan hydrochloride, which bears US NIH Compound Identifier 55917. Most nations, for tariff and trade purposes, schedule imazodan hydrochloride under HS 29332990 and SITC 51573. As of Q4 2014, IMAZODAN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Imazodan hydrochloride bears US NLM identifiers UMLS ID C0956497 and NCI Concept Code C72811. SMILES: C1CC(CCC1C2=NNC(=O)CC2)N3CCNC3.CL.

